Among the BET inhibitors with prominent pro-apoptotic activity, the BRD2/BRD4-selective BETi ABBV-075 strongly triggered apoptosis in AML, NHL, and MM cell lines, and had mainly a broad antiproliferative activity across different solid tumor-derived cell lines [80]. This evidence concerns the gene BRD4 and Miyoshi myopathy.